A unique collection of xnum cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;

A unique collection of xnum diabetes related compounds;

A unique collection of xnum neurotransmitter receptor compounds, can be used for HTS and HCS screening；

A collection of xnum natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.

A unique collection of xnum endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.

A unique collection of xnum stem cell differentiation signaling targeted compounds for high throughput and high content screening;

A unique collection of xnum compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A collection of xnum small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;

A unique collection of xnum antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of xnum anti-obesity compounds for high throughput and high content screening;

A unique collection of xnum promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;

A unique collection of xnum DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consists of xnum compounds without compro

A unique collection of xnum nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;

A unique collection of xnum monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A unique collection of xnum compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；

A unique collection of xnum compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；

xnum peptides can be used in peptide drug development and signaling transduction and mechanism study;

A unique collection of xnum compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;

Well-chosen xnum compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of xnum of orally active compounds for high-throughput screening and high-content screening.

A collection of xnum natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.

xnum types of active small molecules associated with pyroptosis for high-throughput and high-content screening.

A unique collection of xnum compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);

xnum methylation-related compounds that can be used for high-throughput and high-content screening.

A unique collection of xnum compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting serotonin receptors for high throughput screening and high content screening;

A unique collection of xnum mouse metabolites, which can be used for HTS and HCS;

xnum glycometabolism-related comounds, can be used for HTS and HCT;

Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. Disturbances in the normal redox state of cells can cause toxic effects through the production of peroxides and free radicals that damage all components of the cell, including proteins, lipids, and DNA. In humans, oxidative stress is thought to be involved in the development of atherosclerosis, heart failure, myocardial infarction, cancer, infection etc. Antioxidants are a class of compounds that counteract oxidative stress and reduce oxidative damage. The TargetMol Antioxidant Compound Library is a unique collection of xnum small molecules with inhibitory effects on oxidative stress and is a useful tool for high-throughput screening and high-content screening in the study of oxidative stress.

A unique collection of xnum compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A unique collection of xnum compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.

A unique collection of xnum preclinical compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of xnum compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;

A unique collection of xnum beta-lactam compounds, can be used in HTS and HCS;

A unique collection of xnum compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.

A unique collection of xnum ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；

Well-chosen xnum GPCR targeting compounds with unique structures;

A unique collection of xnum antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

xnum non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A collection of xnum TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；